We are live on
!
Find out more
AA
Antipodean Advisors Portfolio holdings
AUM
$19.5M
1-Year Est. Return
6.21%
This Fund
S&P 500
This Quarter
Est. Return
-7.25%
1 Year Est. Return
-6.21%
3 Year Est. Return
-67.79%
5 Year Est. Return
+67.26%
10 Year Est. Return
+1,117.22%
AUM
$29.9M
AUM Growth
-$9.13M
(-23%)
Cap. Flow
-$669K
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$5.64M |
| 2 |
Upstart Holdings
UPST
|
+$193K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carvana
CVNA
|
+$3.48M |
| 2 |
Cardlytics
CDLX
|
+$2.87M |
| 3 |
RSX
VanEck Russia ETF
RSX
|
+$141K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 61.2% |
| 2 | Healthcare | 16.13% |
| 3 | Communication Services | 1.45% |
| 4 | Financials | 0.44% |
Similar funds
CVSCT
DOS
SIC
LUGPI
RCP
IVM
CCFM
VNB
Antipodean Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Antipodean Advisors held 9 positions worth $29.9M, down 23% from $39.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Antipodean Advisors's Q4 2022 filing shows 2 new, 2 reduced and 1 closed positions. Its largest new stake was SPDR Gold Trust: 35,000 shares worth $5.94M. The largest sale was Carvana, an estimated $3.48M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 61% of assets, down from 69% a quarter earlier, followed by Healthcare and Communication Services.
- Antipodean Advisors's largest Q4 2022 buy was SPDR Gold Trust: 35,000 shares worth $5.94M.
- Antipodean Advisors's biggest Q4 2022 reduction was Carvana, cutting an estimated $3.48M.
- Antipodean Advisors fully exited VanEck Russia ETF in Q4 2022, selling an estimated $141K.
- Antipodean Advisors's ten largest holdings make up 100% of its $29.9M portfolio in Q4 2022.
- Antipodean Advisors opened 2 new positions and closed 1 in Q4 2022.
- Antipodean Advisors's portfolio value fell 23% quarter-over-quarter to $29.9M.
Based on Antipodean Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.